UMIN-CTR Clinical Trial

Recruitment status No longer recruiting
Unique ID issued by UMIN UMIN000019555
Receipt No. R000022613
Official scientific title of the study Efficacy of Automated Ablation Annotation Algorithm(Visitag) in Reducing Re-conduction of Isolated Pulmonary Vein and Recurrence after Catheter Ablation for Atrial Fibrillation
Date of disclosure of the study information 2015/10/30
Last modified on 2017/05/19 (Ver. 2)

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information
Official scientific title of the study Efficacy of Automated Ablation Annotation Algorithm(Visitag) in Reducing Re-conduction of Isolated Pulmonary Vein and Recurrence after Catheter Ablation for Atrial Fibrillation
Title of the study (Brief title) Efficacy of Automated Ablation Annotation Algorithm(Visitag) in Reducing Re-conduction of Isolated Pulmonary Vein and Recurrence after Catheter Ablation for Atrial Fibrillation
Region
Japan

Condition
Condition Atrial Fibrillation
Classification by specialty
Cardiology
Classification by malignancy Others
Genomic information NO

Objectives
Narrative objectives1 The purpose of this study is to compare automatic annotation system with manual tag during CPVI using CARTO system and contact force catheter.
Basic objectives2 Safety,Efficacy
Basic objectives -Others
Trial characteristics_1
Trial characteristics_2
Developmental phase

Assessment
Primary outcomes recurrence of atrial fibrillation(1 year)
Key secondary outcomes Spontaneous PV reconnection; Dormant conduction by ATP; duration of energy application ; total energy; procedure time; and complications associated with catheter ablation

Base
Study type Interventional

Study design
Basic design Parallel
Randomization Randomized
Randomization unit Individual
Blinding Open -no one is blinded
Control Active
Stratification NO
Dynamic allocation
Institution consideration
Blocking
Concealment

Intervention
No. of arms 2
Purpose of intervention Treatment
Type of intervention
Maneuver
Interventions/Control_1 RF Ablation using CARTO system. Manual collection of RF ablation points by assistant.
Interventions/Control_2 RF ablation was guided by an automated algorithm with predefined criteria of catheter stability range of motion; 1.5mm ,catheter stability duration ;5 seconds, and force over time (contact force;5g, time;25%). When this condition is satisfied, new tag appears. Tag size was 3mm and we intended to move catheter to next position to appear the new tag where was overlapped with the former tag. When force time integral (FTI) of the tag becomes 100-150gs, the color of tag changed from white to red and we moved catheter to the next position.
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10

Eligibility
Age-lower limit
20 years-old <=
Age-upper limit
80 years-old >
Gender Male and Female
Key inclusion criteria patients undergoing initial ablation for paroxysmal or persistent (duration < 5 year) atrial fibrillation
Key exclusion criteria Patients with sustained atrial fibrillation episode 5 years or greater;
Patients with left atrial size 50 mm or larger or left atrial volume 200ml or larger;
Patients with valvular atrial fibrillation and a history of cardiac surgery;
Patients age is < 20 years or 80 years or greater;
Dialysis patients;
Patients with heart failure (LVEF < 30% or NYHA class III or IV);
Patients taking antiarrhythmic drugs before procedure; or
Patients considered unsuitable for this study
Target sample size 150

Research contact person
Name of lead principal investigator Koichi Inoue
Organization Sakurabashi Watanabe Hospital
Division name Cardiovascular center
Address 2-4-32 Umeda, Kita, Osaka, Japan
TEL 06-6341-8655
Email inoueko1@yahoo.co.jp

Public contact
Name of contact person Nobuaki Tanaka
Organization Sakurabashi Watanabe Hospital
Division name Cardiovascular center
Address 2-4-32 Umeda, Kita, Osaka, Japan
TEL 06-6341-8655
Homepage URL
Email nob-t@tj9.so-net.ne.jp

Sponsor
Institute Sakurabashi Watanabe Hospital
Institute
Department

Funding Source
Organization none
Organization
Division
Category of Funding Organization Self funding
Nationality of Funding Organization

Other related organizations
Co-sponsor
Name of secondary funder(s)

Secondary IDs
Secondary IDs NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW

Institutions
Institutions

Other administrative information
Date of disclosure of the study information
2015 Year 10 Month 30 Day

Progress
Recruitment status No longer recruiting
Date of protocol fixation
2015 Year 10 Month 23 Day
Anticipated trial start date
2015 Year 11 Month 01 Day
Last follow-up date
Date of closure to data entry
Date trial data considered complete
Date analysis concluded

Related information
URL releasing protocol
Publication of results Unpublished
URL releasing results
Results
Other related information

Management information
Registered date
2015 Year 10 Month 29 Day
Last modified on
2017 Year 05 Month 19 Day


Link to view the page
URL(English) https://upload.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000022613